NEA leads a big syndicate on $100M mega-round for Allakos
Five years after getting started with a $32 million Series A, the crew at Allakos in San Carlos, CA are getting a $100 million mega-round to put their lead drug to the test.
New Enterprise Associates led the round for the low profile biotech with a big syndicate that includes Redmile Group, Partner Fund Management, Rock Springs Capital, LifeSci Venture Partners, Samsara BioCapital, and “a large institutional investor,” as well as existing investors Alta Partners, RiverVest Venture Partners, Roche Venture Fund, and 3X5 Partners.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.